Samasha Medical Foundation is supporting the Government of Uganda Ministry of Health’s (MoH) plan for the replacement of Implanon Classic with Implanon NXT following the manufacturer’s decision to completely phase out production of Implanon Classic in October 2015. Uganda is a beneficiary from a volume-guaranteed price by more than 50% to $8.50 per Unit manufacturer Merck Sharp and Dohme (MSD) and as a result, the country has seen significant efforts in recent years to increase uptake of long-acting reversible contraceptives (LARC), especially implants, through scaling up access, demand and trained health worker capacity.
The objectives of the transition plan include the following;
The assignment is for a period of 12 months starting January, 2017- December, 2017